ABSTRACT
Oculodentodigital dysplasia is caused by mutations in the GJA1 gene. Oculodentodigital dysplasia presents with a spectrum of clinical features including craniofacial, ocular, dental, and limb anomalies. Although recent findings implicate the major role of GJA1 during cardiac organogenesis, congenital heart defects are infrequently reported in oculodentodigital dysplasia. Here we report on two patients with GJA1 mutations presenting with cardiac malformations and type III syndactyly. Patient 1 presented with pulmonary atresia, an intact septum, right ventricular hypoplasia and tricuspid stenosis. The infant had a small nose, thin columella and bilateral 4-5 syndactyly of the fingers. A de novo c.226C>T (p.Arg76Cys) mutation was identified. Patient 2 presented at 6 months with a ventricular septal defect. The child had hypoplastic alae nasi with a thin columella and bilateral 4-5 syndactyly of the digits. A de novo missense mutation, c.145C>G (p.Gln49Glu) was found. Our two patients underscore the importance of cardiac evaluations as part of the initial workup for patients with findings of oculodentodigital dysplasia. Conversely, those patients with type III syndactyly and congenital heart defect should be screened for GJA1 mutations.
Subject(s)
Connexin 43/genetics , Craniofacial Abnormalities/genetics , Eye Abnormalities/genetics , Foot Deformities, Congenital/genetics , Heart Defects, Congenital/genetics , Pulmonary Valve Stenosis/genetics , Syndactyly/genetics , Tooth Abnormalities/genetics , Abnormalities, Multiple/genetics , Craniofacial Abnormalities/complications , Craniofacial Abnormalities/physiopathology , Eye Abnormalities/complications , Eye Abnormalities/physiopathology , Female , Fingers/abnormalities , Fingers/physiopathology , Foot Deformities, Congenital/complications , Foot Deformities, Congenital/physiopathology , Heart Defects, Congenital/complications , Heart Defects, Congenital/physiopathology , Heart Septal Defects, Ventricular/complications , Heart Septal Defects, Ventricular/genetics , Heart Septal Defects, Ventricular/physiopathology , Humans , Infant , Infant, Newborn , Male , Mutation , Pulmonary Valve Stenosis/complications , Pulmonary Valve Stenosis/physiopathology , Syndactyly/complications , Syndactyly/physiopathology , Tooth Abnormalities/complications , Tooth Abnormalities/physiopathologyABSTRACT
Prader-Willi syndrome is caused by the loss of paternal gene expression on 15q11.2-q13.2, and one of the mechanisms resulting in Prader-Willi syndrome phenotype is maternal uniparental disomy of chromosome 15. Various mechanisms including trisomy rescue, monosomy rescue, and post fertilization errors can lead to uniparental disomy, and its mechanism can be inferred from the pattern of uniparental hetero and isodisomy. Detection of a mosaic cell line provides a unique opportunity to understand the mechanism of uniparental disomy; however, mosaic uniparental disomy is a rare finding in patients with Prader-Willi syndrome. We report on two infants with Prader-Willi syndrome caused by mosaic maternal uniparental disomy 15. Patient 1 has mosaic uniparental isodisomy of the entire chromosome 15, and Patient 2 has mosaic uniparental mixed iso/heterodisomy 15. Genome-wide single-nucleotide polymorphism array was able to demonstrate the presence of chromosomally normal cell line in the Patient 1 and trisomic cell line in Patient 2, and provide the evidence that post-fertilization error and trisomy rescue as a mechanism of uniparental disomy in each case, respectively. Given its ability of detecting small percent mosaicism as well as its capability of identifying the loss of heterozygosity of chromosomal regions, genome-wide single-nucleotide polymorphism array should be utilized as an adjunct to the standard methylation analysis in the evaluation of Prader-Willi syndrome.
Subject(s)
Chromosomes, Human, Pair 15/genetics , Genome-Wide Association Study , Mosaicism , Polymorphism, Single Nucleotide , Prader-Willi Syndrome/genetics , Uniparental Disomy/genetics , Female , Genetic Loci , Genome , Humans , Infant, Newborn , Microarray Analysis , Phenotype , Prader-Willi Syndrome/diagnosis , Trisomy , snRNP Core Proteins/geneticsABSTRACT
Braddock-Carey syndrome is characterized by Pierre Robin sequence, agenesis of the corpus callosum, facial dysmorphisms, developmental delay, and congenital thrombocytopenia. Recently, Braddock-Carey syndrome was demonstrated to be caused by chromosomal microdeletion in 21q22 including the RUNX1 gene, whose haploinsufficiency is responsible for thrombocytopenia phenotype. Therefore, the syndrome has emerged as a contiguous gene deletion syndrome. Here, we describe an infant with Pierre Robin sequence, facial anomalies, congenital heart defects, hypotonia, and the absence of thrombocytopenia, who was found to have a 1.9 Mb microdeletion within the Braddock-Carey contiguous deletion syndrome region. This deletion spares the RUNX1 gene, narrowing the genomic region responsible for a part of the Braddock-Carey syndrome phenotype. Further studies are awaited to understand the role of the genes located within 21q22 in the pathogenesis of Braddock-Carey syndrome.
Subject(s)
Agenesis of Corpus Callosum , Chromosome Deletion , Chromosomes, Human, Pair 21 , Facies , Growth Disorders , Phenotype , Pierre Robin Syndrome , Thrombocytopenia/congenital , Abnormalities, Multiple/diagnosis , Abnormalities, Multiple/genetics , Comparative Genomic Hybridization , Female , Humans , Infant , KaryotypingABSTRACT
Renal coloboma syndrome, also known as papillorenal syndrome is an autosomal-dominant disorder characterized by ocular and renal malformations. Mutations in the paired-box gene, PAX2, have been identified in approximately half of individuals with classic findings of renal hypoplasia/dysplasia and abnormalities of the optic nerve. Prior to 2011, there was no actively maintained locus-specific database (LSDB) cataloguing the extent of genetic variation in the PAX2 gene and phenotypic variation in individuals with renal coloboma syndrome. Review of published cases and the collective diagnostic experience of three laboratories in the United States, France, and New Zealand identified 55 unique mutations in 173 individuals from 86 families. The three clinical laboratories participating in this collaboration contributed 28 novel variations in 68 individuals in 33 families, which represent a 50% increase in the number of variations, patients, and families published in the medical literature. An LSDB was created using the Leiden Open Variation Database platform: www.lovd.nl/PAX2. The most common findings reported in this series were abnormal renal structure or function (92% of individuals), ophthalmological abnormalities (77% of individuals), and hearing loss (7% of individuals). Additional clinical findings and genetic counseling implications are discussed.
Subject(s)
Coloboma/genetics , Databases, Genetic , PAX2 Transcription Factor/genetics , Renal Insufficiency/genetics , Vesico-Ureteral Reflux/genetics , Animals , HumansABSTRACT
Legius syndrome, is a recently identified autosomal dominant disorder caused by loss of function mutations in the SPRED1 gene, with individuals mainly presenting with multiple café-au-lait macules (CALM), freckling and macrocephaly. So far, only SPRED1 point mutations have been identified as the cause of this syndrome. To determine if copy number changes (CNCs) are a cause of Legius syndrome, we have used a Multiplex Ligation-dependent Probe Amplification (MLPA) assay covering all SPRED1 exons in a cohort of 510 NF1-negative patients presenting with multiple CALMs with or without freckling, but no other NF1 diagnostic signs. Four different deletions were identified by MLPA and confirmed by quantitative PCR, reverse transcriptase PCR and/or array CGH: a deletion of exon 1 and the SPRED1 promoter region in a proband and two first-degree relatives; a deletion of the entire SPRED1 gene in a sporadic patient; a deletion of exon 2-6 in a proband and her father; and an â¼6.6 Mb deletion on chromosome 15 that spans SPRED1 in a sporadic patient. Deletions account for â¼10% of the 40 detected SPRED1 mutations in this cohort of 510 individuals. These results indicate the need for dosage analysis to complement sequencing-based SPRED1 mutation analyses.
Subject(s)
Cafe-au-Lait Spots/genetics , Gene Dosage/genetics , Intracellular Signaling Peptides and Proteins/genetics , Membrane Proteins/genetics , Sequence Deletion/genetics , Adaptor Proteins, Signal Transducing , Comparative Genomic Hybridization , DNA Primers/genetics , Humans , Nucleic Acid Amplification Techniques/methods , Polymerase Chain Reaction/methods , Reverse Transcriptase Polymerase Chain ReactionABSTRACT
OBJECTIVE: psychiatric disorders are profoundly stigmatized conditions. Many groups of healthcare professionals harbor negative attitudes towards affected individuals, which may interfere with the healthcare relationship, but genetic counselors' attitudes towards individuals with psychiatric disorders have not been investigated. Thus, we conducted an exploratory study to assess genetic counselors' desire for social distance from individuals with schizophrenia, and the degree to which stereotypes about people with schizophrenia were endorsed. METHODS: members of the National Society of Genetic Counselors were invited to complete an online survey, which included scales measuring: desire for social distance from individuals with schizophrenia, and endorsement of positive and negative stereotypes about these individuals. RESULTS: in total, 142 surveys were completed. Genetic counselors expressed greater desire for social distance from an individual with schizophrenia in more intimate proposed relationship scenarios, and felt negative stereotypes about affected individuals were more typifying than positive stereotypes. Experience with psychiatric disorders did not significantly affect desired social distance or stereotypical attitudes. CONCLUSIONS: genetic counselors express some negative attitudes towards individuals with schizophrenia, which may impede the counselor/client relationship. Future research in this area is suggested. PRACTICE IMPLICATIONS: efforts should be made to promote positive attitudes, which would improve the ability of genetic counselors to provide optimal service for individuals with schizophrenia and their families.
Subject(s)
Attitude of Health Personnel , Health Personnel/psychology , Psychological Distance , Schizophrenia , Adult , Female , Genetic Counseling/psychology , Humans , Interpersonal Relations , Male , Middle Aged , Prejudice , Professional-Patient Relations , Socioeconomic Factors , Stereotyping , Surveys and Questionnaires , Young AdultABSTRACT
We report on the novel association of trigonocephaly and polysyndactyly in two unrelated patients due to mutations within the last third (exon 14) and first third (exon 6) of the GLI3 gene, respectively. GLI3 acts as a downstream mediator of the Sonic hedgehog signal-transduction pathway which is essential for early development; and plays a role in cell growth, specialization, and patterning of structures such as the brain and limbs. GLI3 mutations have been identified in patients with Pallister-Hall, Grieg cephalopolysyndactyly syndrome (GCPS), postaxial polydactyly type A1, preaxial polydactyly type IV, and in one patient with acrocallosal syndrome (ACLS). Furthermore, deletions including the GLI3 gene have been reported in patients with features of GCPS and ACLS. To date, trigonocephaly has not been associated with abnormalities of GLI3 and craniosynostosis is not a feature of GCPS. However, Hootnick and Holmes reported on a father with polysyndactyly and son with trigonocephaly, polysyndactyly, and agenesis of the corpus callosum, considered GCPS thereafter. Guzzetta et al. subsequently described a patient with trigonocephaly, polysyndactyly, and agenesis of the corpus callosum postulating a diagnosis of GCPS, later considered ACLS. In retrospect, these two patients, evaluated prior to mutational analysis, and our patients, with confirmed mutations, likely fall within the GLI3 morphopathy spectrum and may provide a bridge to better understanding those patients with overlapping features of GCPS and ACLS. Based on this observation, we suggest GLI3 studies in patients presenting with this constellation of findings, specifically metopic craniosynostosis with polysyndactyly, in order to provide appropriate medical management and genetic counseling.